Progress of antibody-drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies.
Mer AH, Mirzaei Y, Misamogooe F, Bagheri N, Bazyari A, Keshtkaran Z, Meyfour A, Shahedi A, Amirkhani Z, Jafari A, Barpour N, Jahandideh S, Rezaei B, Nikmanesh Y, Abdollahpour-Alitappeh M.
Mer AH, et al. Among authors: jahandideh s.
Drug Deliv Transl Res. 2024 Apr 10. doi: 10.1007/s13346-024-01564-3. Online ahead of print.
Drug Deliv Transl Res. 2024.
PMID: 38597995
Review.